T. thermophilus RNAP core enzyme was prepared from
T. thermophilus strain H8 (DSM 579; DSMZ), using cell lysis, polyethylenimine precipitation, ammonium sulfate precipitation, cation-exchange chromatography on
SP Sepharose FF (GE Healthcare), anion-exchange chromatography on
Mono Q 10/100 GL (GE Healthcare), and cation-exchange chromatography on Mono S HR (GE Healthcare), as in Zhang et al., 2012 (
link) and Maffioli et al., 2017 (
link).
T. thermophilus σ
A was prepared by co-expression of a gene for N-terminally hexahistidine-tagged
T. thermophilus σ
A in
E. coli, followed by cell lysis, immobilized-metal-ion affinity chromatography on
Ni-NTA agarose (Qiagen) and anion-exchange chromatography on
Mono Q (GE Healthcare), as in Zhang et al., 2012 (
link).
T. thermophilus RNAP σ
A holoenzyme was prepared by combining
T. thermophilus RNAP core enzyme and
T. thermophilus σ
A, followed by size-exclusion chromatography on
Superdex 200 (GE Healthcare), as in Zhang et al., 2014 (
link).
Lin W., Das K., Degen D., Mazumder A., Duchi D., Wang D., Ebright Y.W., Ebright R.Y., Sineva E., Gigliotti M., Srivastava A., Mandal S., Jiang Y., Liu Y., Yin R., Zhang Z., Eng E.T., Thomas D., Donadio S., Zhang H., Zhang C., Kapanidis A.N, & Ebright R.H. (2018). STRUCTURAL BASIS OF TRANSCRIPTION INHIBITION BY FIDAXOMICIN (LIPIARMYCIN A3). Molecular cell, 70(1), 60-71.e15.